Skip to content
StockMarketAgent
Healthcare / Medical - SpecialtiesUpdated 2026-05-10 22:07 UTC

KOSDAQ/099430 stock hub

KOSDAQ/099430 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/099430is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
350.8B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/099430
In the news

Latest news · KOSDAQ/099430

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/E38.3
P25 12P50 23.1P75 39.5
ROE11.5
P25 -17.1P50 0.7P75 8.5
ROIC6.7
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/099430 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
213
Groups with data
11
Currency
KRW
Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
South Korea
Country code
KR
Enterprise value
KRW 403.8B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Medical - Specialties
Isin
KR7099430001
Last refreshed
2026-05-10
Market cap
KRW 350.8B
Price
KRW 5,700
Price currency
KRW
Sector
Healthcare
Sic
3841
Symbol
kosdaq/099430
Website
https://www.bioplus.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
4.28%
EV Earnings
26.92x
EV/EBIT
27.33x
EV/EBITDA
21.43x
EV/FCF
-13.96x
EV/Sales
4.44x
FCF yield
-8.25%
P/B ratio
1.8x
P/E ratio
38.26x
P/S ratio
3.86x
PE Ratio3 Y
19.76x
PE Ratio5 Y
23.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
16.49%
EBITDA Margin
20.96%
Gross margin
66.6%
Gross Profit
KRW 60.5B
Gross Profit Growth
42.29%
Gross Profit Growth Q
-29.87%
Gross Profit Growth3 Y
21.47%
Gross Profit Growth5 Y
29.61%
Net Income
KRW 15B
Net Income Growth
6.01%
Net Income Growth Q
-34.35%
Net Income Growth Years
1%
Net Income Growth3 Y
-10.8%
Net Income Growth5 Y
9.11%
Pretax Margin
19.29%
Profit Margin
16.5%
Profitable Years
7
ROA
3.41
Roa5y
10.56
ROCE
7.22
ROE
11.51
Roe5y
17.2
ROIC
6.75
Roic5y
31.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr1y
-25.34%
Cagr3y
-3.05%
Div CAGR3
0%
EPS Growth
-39.68
EPS Growth Q
-65.61
EPS Growth Years
0
EPS Growth3 Y
-26.23
EPS Growth5 Y
-4.62
OCF Growth
-33.35%
OCF Growth Q
-17.39%
OCF Growth3 Y
9.74%
OCF Growth5 Y
11.94%
Revenue Growth
36.87x
Revenue Growth Q
-20.3x
Revenue Growth Years
6x
Revenue Growth3 Y
17.02x
Revenue Growth5 Y
30.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
KRW 0.33
Assets
KRW 285B
Cash
KRW 27.2B
Current Assets
KRW 64.8B
Current Liabilities
KRW 77.3B
Debt
KRW 60.1B
Debt EBITDA
KRW 3.15
Debt Equity
KRW 0.31
Debt FCF
KRW -2.08
Equity
KRW 195B
Interest Coverage
49.36
Liabilities
KRW 90.1B
Long Term Assets
KRW 220.3B
Long Term Liabilities
KRW 12.8B
Net Cash
KRW -32.9B
Net Cash By Market Cap
KRW -9.37
Net Debt EBITDA
KRW 1.73
Net Debt Equity
KRW 0.17
Tangible Book Value
KRW 166.1B
Tangible Book Value Per Share
KRW 2,707
WACC
6.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.84
Inventory Turnover
2.37
Net Working Capital
KRW 15.8B
Quick ratio
0.52
Working Capital
KRW -12.5B
Working Capital Turnover
KRW -4.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-75.73%
Dividend Growth
40%
Dividend Growth Years
1%
Dividend per share
KRW 70
Dividend Years
4
Dividend Yield
1.23%
Ex Div Date
2025-12-29
Last Dividend
KRW 70
Payout Frequency
Annual
Payout Ratio
19.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-25.32%
200-day SMA
5,864.6
3Y total return
-8.88%
50-day SMA
5,296.5
50-day SMA vs 200-day SMA
50under200
All Time High
10,750
All Time High Change
-46.98%
All Time High Date
2021-09-27
All Time Low
4,250
All Time Low Change
34.12%
All Time Low Date
2024-06-04
ATR
238.6
Beta
0.58
Beta1y
0.52
Beta2y
0.37
Ch YTD
13.32
High
5,750
High52
8,420
High52 Date
2025-05-09
High52ch
-32.3%
Low
5,520
Low52
4,510
Low52 Date
2026-03-04
Low52ch
26.39%
Ma50ch
7.62%
Price vs 200-day SMA
-2.81%
RSI
53.88
RSI Monthly
46.9
RSI Weekly
52.03
Sharpe ratio
-0.56x
Sortino ratio
-0.66
Total Return
-74.51%
Tr YTD
13.32
Tr1m
13.1%
Tr1w
-2.9%
Tr3m
11.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
KRW 15B
Operating Income Growth
-36.67
Operating Income Growth Q
-93.14
Operating Income Growth3 Y
-16.34
Operating Income Growth5 Y
3.99
Operating margin
16.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
43,156,007%
Net Borrowing
405,524,300
Shares Insiders
29.2%
Shares Institutions
4.9%
Shares Out
61,540,462
Shares Qo Q
237.15%
Shares Yo Y
75.73%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
KRW -28.9B
Average Volume
387,238.55x
Bv Per Share
2,849.4
CAPEX
KRW -46.6B
Ch1m
13.1
Ch1w
-2.9
Ch1y
-26.07
Ch3m
11.33
Ch3y
-11.35
Ch6m
-4.36
Change
1.06%
Change From Open
1.79
Close
5,640
Days Gap
-0.71
Depreciation Amortization
4,063,495,660
Dollar Volume
2,085,316,500
Earnings Date
2026-04-03
EBIT
KRW 15B
EBITDA
KRW 19.1B
EPS
KRW 149
F Score
7
FCF
KRW -28.9B
FCF EV Yield
-7.16x
FCF Per Share
KRW -470
Financing CF
14,151,002,190
Fiscal Year End
December
Founded
2,003
Goodwill
3,043,255,800
Graham Number
3090.72929
Graham Upside
-45.78
Income Tax
KRW -2.5B
Investing CF
-49,527,540,380
Is Primary Listing
1
Last Earnings Date
2026-02-12
Last Report Date
2025-12-31
Last Split Date
2022-11-23
Last Split Type
Forward
Lynch Fair Value
KRW 1,357
Lynch Upside
-76.2
Ma150
5,583.6
Ma150ch
2.08%
Ma20
5,663.5
Ma20ch
0.64%
Net CF
-17,564,964,000
Open
5,600
P OCF Ratio
19.87
Payment Date
2026-04-13
Position In Range
78.26
Ppne
195,414,108,780
Price Date
2026-05-08
Price EBITDA
KRW 18.41
Ptbv Ratio
2.11
Relative Volume
0.97x
Revenue
90,896,012,960x
Tax By Revenue
-2.71x
Tr6m
-3.4%
Volume
365,845
Z Score
3.54
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KOSDAQ/099430 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+1.2%
$70.0 annual per share
Payout ratio
+19.4%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
1 consecutive years of growth
Total shareholder yield
-74.5%
Next ex-dividend date: 2025-12-29
Performance

KOSDAQ/099430 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-25.3%
S&P 500 1Y: n/a
3Y total return
-8.9%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/099430?

Insider, institutional, and short-interest positioning.

Institutional ownership
+4.9%
Share of float held by funds and institutions
Insider ownership
+29.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+75.7%
Negative means the company is buying back shares.
Technical

KOSDAQ/099430 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.9
Neutral momentum band
Price vs 200-day MA
-2.8%
50/200-day relationship not available
Beta (5Y)
0.58
Less volatile than the market
Sharpe ratio
-0.56
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/099430

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/099430 stock rating?

kosdaq/099430 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/099430 analysis?

The full report lives at /stocks/kosdaq/099430/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/099430?

The latest report frames kosdaq/099430 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/099430 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.